Literature DB >> 31815900

Normothermic Ex Vivo Kidney Perfusion Improves Early DCD Graft Function Compared With Hypothermic Machine Perfusion and Static Cold Storage.

Peter Urbanellis1,2, Matyas Hamar1,3,4, J Moritz Kaths1,2, Dagmar Kollmann1, Ivan Linares1,2, Laura Mazilescu1,2, Sujani Ganesh1, Aryn Wiebe1, Paul M Yip5, Rohan John5, Ana Konvalinka6,7, Istvan Mucsi8, Anand Ghanekar1, Darius J Bagli2,9, Lisa A Robinson2,3,10, Markus Selzner1,2.   

Abstract

BACKGROUND: Better preservation strategies for the storage of donation after circulatory death grafts are essential to improve graft function and to increase the kidney donor pool. We compared continuous normothermic ex vivo kidney perfusion (NEVKP) with hypothermic anoxic machine perfusion (HAMP) and static cold storage (SCS) in a porcine kidney autotransplantation model.
METHODS: Porcine kidneys were exposed to 30 minutes of warm ischemia and then reimplanted following either 16 hours of either SCS, HAMP (LifePort 1.0), or NEVKP before autotransplantation (n = 5 per group). The contralateral kidney was removed. Animals were followed for 8 days.
RESULTS: Grafts preserved by NEVKP demonstrated improved function with more rapid recovery compared with HAMP and SCS (mean peak serum creatinine: 3.66 ± 1.33 mg/dL [postoperative d 1 [(POD1)], 8.82 ± 3.17 mg/dL [POD2], and 12.90 ± 2.19 mg/dL [POD3], respectively). The NEVKP group demonstrated significantly increased creatinine clearance calculated on POD3 (63.6 ± 19.0 mL/min) compared with HAMP (13.5 ± 10.3 mL/min, P = 0.001) and SCS (4.0 ± 2.6 mL/min, P = 0.001). Histopathologic injury scores on POD8 were lower in both perfused groups (NEVKP and HAMP, score: 1-1.5) compared with SCS (score: 1-3, P = 0.3), without reaching statistical significance.
CONCLUSIONS: NEVKP storage significantly improved early kidney function compared with both cold preservation strategies, although HAMP also demonstrates improvement over SCS. NEVKP may represent a novel, superior preservation option for donation after circulatory death renal grafts compared with conventional hypothermic methods.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31815900     DOI: 10.1097/TP.0000000000003066

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  20 in total

1.  Development and Characterization of a Nonelectronic Versatile Oxygenating Perfusion System for Tissue Preservation.

Authors:  Daniel J Portillo; Jose Gonzalez; Carorina Villarreal; Sophia J Salazar; Anjelyka Fasci; Brandt Wearden; Jessica Oseghale; Anis Khalil; Thomas Perillo; Leslie Muenchow; Robert De Lorenzo; R Lyle Hood
Journal:  Ann Biomed Eng       Date:  2022-06-01       Impact factor: 3.934

Review 2.  What is the evidence for oxygenation during kidney preservation for transplantation in 2021? A scoping review.

Authors:  B Mesnard; A E Ogbemudia; G Karam; F Dengu; G Hackim; J Rigaud; G Blancho; S Drouin; M O Timsit; J Branchereau
Journal:  World J Urol       Date:  2021-08-25       Impact factor: 3.661

Review 3.  Recent Methods of Kidney Storage and Therapeutic Possibilities of Transplant Kidney.

Authors:  Anna Radajewska; Anna Krzywonos-Zawadzka; Iwona Bil-Lula
Journal:  Biomedicines       Date:  2022-04-28

4.  Significant Dysfunction of Kidney Grafts Exposed to Prolonged Warm Ischemia Is Minimized Through Normothermic Ex Vivo Kidney Perfusion.

Authors:  Peter Urbanellis; Dagmar Kollmann; Ivan Linares; Sujani Ganesh; Fabiola Oquendo; Laura Mazilescu; Toru Goto; Yuki Noguchi; Rohan John; Ana Konvalinka; Istvan Mucsi; Anand Ghanekar; Darius Bagli; Markus Selzner; Lisa A Robinson
Journal:  Transplant Direct       Date:  2020-07-22

Review 5.  Sense and Sensibilities of Organ Perfusion as a Kidney and Liver Viability Assessment Platform.

Authors:  Laurence Verstraeten; Ina Jochmans
Journal:  Transpl Int       Date:  2022-03-14       Impact factor: 3.782

6.  Improved Normothermic Machine Perfusion After Short Oxygenated Hypothermic Machine Perfusion of Ischemically Injured Porcine Kidneys.

Authors:  Stina Lignell; Stine Lohmann; Kaithlyn M Rozenberg; Henri G D Leuvenink; Merel B F Pool; Kate R Lewis; Cyril Moers; James P Hunter; Rutger J Ploeg; Marco Eijken; Ulla Møldrup; Søren Krag; Carla C Baan; Bjarne Kuno Møller; Anna Krarup Keller; Bente Jespersen
Journal:  Transplant Direct       Date:  2021-01-15

Review 7.  Shifting Paradigms for Suppressing Fibrosis in Kidney Transplants: Supplementing Perfusion Solutions With Anti-fibrotic Drugs.

Authors:  L Leonie van Leeuwen; Henri G D Leuvenink; Peter Olinga; Mitchel J R Ruigrok
Journal:  Front Med (Lausanne)       Date:  2022-01-10

Review 8.  Ex-vivo Kidney Machine Perfusion: Therapeutic Potential.

Authors:  Ruta Zulpaite; Povilas Miknevicius; Bettina Leber; Kestutis Strupas; Philipp Stiegler; Peter Schemmer
Journal:  Front Med (Lausanne)       Date:  2021-12-24

Review 9.  Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials.

Authors:  Rossana Franzin; Alessandra Stasi; Marco Fiorentino; Simona Simone; Rainer Oberbauer; Giuseppe Castellano; Loreto Gesualdo
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

Review 10.  Perfluorocarbon-based oxygen carriers: from physics to physiology.

Authors:  Johannes Jägers; Anna Wrobeln; Katja B Ferenz
Journal:  Pflugers Arch       Date:  2020-11-03       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.